Company registration number 14900485 (England and Wales)
QR PRIVATE MEDICAL SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
QR PRIVATE MEDICAL SERVICES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
QR PRIVATE MEDICAL SERVICES LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
31 March 2026
31 May 2025
Notes
£
£
£
£
Current assets
Stocks
7,104
-
Debtors
3
1,277
6
Cash at bank and in hand
34,528
37,740
42,909
37,746
Creditors: amounts falling due within one year
4
(17,865)
(16,157)
Net current assets
25,044
21,589
Capital and reserves
Called up share capital
5
6
6
Profit and loss reserves
25,038
21,583
Total equity
25,044
21,589

For the financial period ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 13 August 2026 and are signed on its behalf by:
Mr C Porter
Director
Company registration number 14900485 (England and Wales)
QR PRIVATE MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2026
- 2 -
1
Accounting policies
Company information

QR Private Medical Services Limited is a private company limited by shares incorporated in England and Wales. The registered office is RMT Accountants & Business Advisors Ltd, C/O RMT Accountants and Business Advisors Ltd, Gosforth Park Avenue, Newcastle Upon Tyne, NE12 8EG.

1.1
Reporting period

The company has prepared a 44 week set of accounts running to 31 March 2026, being the desired year end, therefore the results are not entirely comparable with the prior year.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Revenue

Revenue is recognised at the fair value of the consideration received or receivable for private medical services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

QR PRIVATE MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 3 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2026
2025
Total
6
6
QR PRIVATE MEDICAL SERVICES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2026
- 4 -
3
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
1,271
-
0
Other debtors
6
6
1,277
6
4
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
9,213
10,889
Corporation tax
810
4,848
Other taxation and social security
4,789
-
0
Accruals and deferred income
3,053
420
17,865
16,157
5
Called up share capital
2026
2025
Ordinary share capital
£
£
Issued and fully paid
Ordinary shares of £1 each
6
6
2026-03-31 2025-06-01 false false false 13 August 2026 CCH Software CCH Accounts Production 2026.200 No description of principal activity Mr J Blackburn-Wood Dr S Duck Mr C Porter Dr H Versey Dr J Worthy Dr A Clarke Dr B Hattaway Mrs C Moses 14900485 2025-06-01 2026-03-31 14900485 2026-03-31 14900485 2025-05-31 14900485 core:WithinOneYear 2026-03-31 14900485 core:WithinOneYear 2025-05-31 14900485 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 14900485 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 14900485 core:ShareCapital 2026-03-31 14900485 core:ShareCapital 2025-05-31 14900485 core:RetainedEarningsAccumulatedLosses 2026-03-31 14900485 core:RetainedEarningsAccumulatedLosses 2025-05-31 14900485 core:ShareCapitalOrdinaryShareClass1 2026-03-31 14900485 core:ShareCapitalOrdinaryShareClass1 2025-05-31 14900485 bus:Director3 2025-06-01 2026-03-31 14900485 2024-06-01 2025-05-31 14900485 core:CurrentFinancialInstruments 2026-03-31 14900485 core:CurrentFinancialInstruments 2025-05-31 14900485 bus:OrdinaryShareClass1 2025-06-01 2026-03-31 14900485 bus:PrivateLimitedCompanyLtd 2025-06-01 2026-03-31 14900485 bus:SmallCompaniesRegimeForAccounts 2025-06-01 2026-03-31 14900485 bus:FRS102 2025-06-01 2026-03-31 14900485 bus:AuditExemptWithAccountantsReport 2025-06-01 2026-03-31 14900485 bus:Director1 2025-06-01 2026-03-31 14900485 bus:Director2 2025-06-01 2026-03-31 14900485 bus:Director4 2025-06-01 2026-03-31 14900485 bus:Director5 2025-06-01 2026-03-31 14900485 bus:Director6 2025-06-01 2026-03-31 14900485 bus:Director7 2025-06-01 2026-03-31 14900485 bus:Director8 2025-06-01 2026-03-31 14900485 bus:FullAccounts 2025-06-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP